Sorrento Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Sorrento Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketlines Sorrento Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sorrento Therapeutics, Inc. since January2007.

Synopsis

Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Sorrento Therapeutics, Inc.s contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Sorrento Therapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Sorrento Therapeutics, Inc.s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Sorrento Therapeutics, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Sorrento Therapeutics, Inc.s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Sorrento Therapeutics, Inc.s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.


COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions - Overview
--Mergers and Acquisitions - Deal reports
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports
DIVESTMENTS
--Divestments - Overview
--Divestments - Deal reports
PRIVATE EQUITY & OWNERSHIP
--Private Equity and Ownership - Overview
--Private Equity and Ownership - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

List Of Tables



--Sorrento Therapeutics activity by deal type - volume (2013 -YTD2017)
--Sorrento Therapeutics M&A average deal size - value ($m) (2013 -YTD2017)
--Sorrento Therapeutics legal advisor ranking by value ($m)
--Sorrento Therapeutics financial advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--Sorrento Therapeutics targets and partners (2013 -YTD2017)
--Sorrento Therapeutics M&A volume and value trend (2013-YTD2017)
--Sorrento Therapeutics M&A activity by geography (2013-YTD2017)
--Sorrento Therapeutics partnership volume and value trend (2013-YTD2017)
--Sorrento Therapeutics partnership trend by key deal type (2013-YTD2017)
--Sorrento Therapeutics capital raising volume and value trend (2013-YTD2017)
--Sorrento Therapeutics capital raising by deal type (2013-YTD2017)
--Sorrento Therapeutics divestments volume and value trend (2013-YTD2017)
--Sorrento Therapeutics divestments activity by geography (2013-YTD2017)
--Sorrento Therapeutics private equity and ownership volume and value trend (2013-YTD2017)
--Sorrento Therapeutics private equity and ownership activity by deal type (2013-YTD2017)

List Of Figures



--Sorrento Therapeutics activity by deal type - volume (2013-YTD2017)
--Sorrento Therapeutics M&A average deal size - value ($m)
--Sorrento Therapeutics M&A volume and value trend (2013-YTD2017)
--Sorrento Therapeutics M&A activity by geography (2013-YTD2017)
--Sorrento Therapeutics partnership volume and value trend (2013-YTD2017)
--Sorrento Therapeutics partnership trend by key deal type (2013-YTD2017)
--Sorrento Therapeutics capital raising volume and value trend (2013-YTD2017)
--Sorrento Therapeutics capital raising by deal type (2013-YTD2017)
--Sorrento Therapeutics divestments volume and value trend (2013-YTD2017)
--Sorrento Therapeutics divestments by geography (2013-YTD2017)
--Sorrento Therapeutics private equity and ownership volume and value trend (2013-YTD2017)
--Sorrento Therapeutics private equity and ownership by deal type (2013-YTD2017)

Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review

Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Oncternal Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report

Oncternal Therapeutics, Inc. - Strategy, SWOT and Corporate Finance ReportOncternal Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review

Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available